Redasemtide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Redasemtide, covering 2026-02-03 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke [Phase 2]